James A. Schoeneck

2017 - DepoMed

In 2017, James A. Schoeneck earned a total compensation of $4.5M as Former President and Chief Executive Officer at DepoMed, a 27% decrease compared to previous year.

Compensation breakdown

Option Awards$1,785,977
Salary$196,266
Stock Awards$1,794,450
Other$737,477
Total$4,514,170

Schoeneck received $1.8M in stock awards, accounting for 40% of the total pay in 2017.

Schoeneck also received $1.8M in option awards, $196.3K in salary and $737.5K in other compensation.

Rankings

In 2017, James A. Schoeneck's compensation ranked 2,182nd out of 14,666 executives tracked by ExecPay. In other words, Schoeneck earned more than 85.1% of executives.

ClassificationRankingPercentile
All
2,182
out of 14,666
85th
Division
Manufacturing
752
out of 5,768
87th
Major group
Chemicals And Allied Products
202
out of 2,074
90th
Industry group
Drugs
153
out of 1,730
91st
Industry
Pharmaceutical Preparations
119
out of 1,329
91st
Source: SEC filing on March 27, 2018.

Schoeneck's colleagues

We found five more compensation records of executives who worked with James A. Schoeneck at DepoMed in 2017.

2017

Arthur Higgins

DepoMed

Chief Executive Officer

2017

Matthew Gosling

DepoMed

General Counsel

2017

August Moretti

DepoMed

Chief Financial Officer

2017

Srinivas Rao

DepoMed

Chief Medical Officer

2017

Santosh Vetticaden

DepoMed

Chief Medical Officer

News

You may also like